Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 47.40% is 46% above its 5-year average of 32.48%, near the high end of its 5-year range (23.90%–47.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.51% above its 12-month average of 36.04%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 47.40%.
DEBT TO ASSETS RATIO
47.40%
DEBT TO ASSETS RATIO AVG TTM
36.04%
DEBT TO ASSETS RATIO AVG 3Y
37.98%
DEBT TO ASSETS RATIO AVG 5Y
32.48%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+31.51%
CURRENT VS 3Y AVG
+24.81%
CURRENT VS 5Y AVG
+45.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 584 covered companies
CURRENT VS SECTOR MEDIAN
+47299.64%
vs the sector median at left
Health Catalyst, Inc.
Market Cap
$129.68M
Debt to Assets Ratio
47.40%
TTM Avg
36.04%
3Y Avg
37.98%
5Y Avg
32.48%
Market Cap
$137.77M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$138.27M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.92M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.68M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $129.68M | 47.40% | 36.04% | 37.98% | 32.48% |
| Freenome, Inc. (FRNM)vs › | $133.86M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $124.95M | 0.02% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.69M | 0.10% | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $122.13M | 0.10% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $137.77M | 0.20% | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $138.27M | 0.36% | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | 0.12% | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.68M | 0.01% | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $140.05M | 0.12% | N/A | N/A | N/A |
Debt/Assets
47.4%
Debt/Equity
1.69
Current Ratio
2.70
Interest Coverage
-2.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 47.40% |
| 2026-03-31 | 41.38% |
| 2025-12-31 | 34.07% |
| 2025-09-30 | 29.32% |
| 2025-06-30 | 28.04% |
| 2025-03-31 | 45.13% |
| 2024-12-31 | 46.83% |
| 2024-09-30 | 44.81% |
| 2024-06-30 | 35.95% |
| 2024-03-31 | 35.80% |
| 2023-12-31 | 35.49% |
| 2023-09-30 | 34.97% |
| 2023-06-30 | 34.52% |
| 2023-03-31 | 32.93% |
| 2022-12-31 | 32.96% |
| 2022-09-30 | 31.98% |
| 2022-06-30 | 30.62% |
| 2022-03-31 | 30.12% |
| 2021-12-31 | 24.59% |
| 2021-09-30 | 23.90% |
| 2021-06-30 | 35.46% |
| 2021-03-31 | 34.56% |
| 2020-12-31 | 33.80% |
| 2020-09-30 | 33.80% |
| 2020-06-30 | 38.46% |
| 2020-03-31 | 16.89% |
| 2019-12-31 | 17.42% |
| 2019-09-30 | 16.61% |
| 2019-06-30 | 38.38% |
| 2019-03-31 | 37.42% |
| 2018-12-31 | 24.25% |
